Indoc Research
Indoc Research is a not-for-profit focused on catalyzing innovative research partnerships through data.
Data should know no bounds. Outputs of research in the agricultural sector can benefit researchers focused on climate change. Research on economic inequality could leverage health system data to develop more finely-tuned interventions.
We’re focused on making these cross-sectoral partnerships happen at scale by creating and supporting networks of researchers and data
Indero
Formerly Innovaderm, Indero is a dual-focus CRO specializing in dermatology and rheumatology. With deep expertise in immune-mediated inflammatory diseases, they deliver end-to-end clinical research with a strong patient-centered approach. By combining scientific rigor with therapeutic focus, Indero is helping to advance innovative care in two complex, intersecting fields.
Innovative Medicines Canada – Rx&D
Innovative Medicines Canada represents Canada’s innovative pharmaceutical industry. We help our members discover, develop and deliver innovative medicines and vaccines.
Our member companies, which range from fledgling start-ups to established organizations, are revolutionizing healthcare through the discovery and development of new medicines and vaccines.
Our industry supports 107,000 high-quality, well-paying jobs in Canada and invests $2.4 billion in R&D every year. Collectively, our activities contribute $15.9 billion per year to Canada’s knowledge-based economy.
Guided by a strict Code of Ethical Practices, we work with governments, insurance companies, healthcare professionals and other stakeholders to advance the field of pharmaceutical research and development and enhance the wellbeing of Canadians. We are committed to being valued partners in Canada’s healthcare system.
We achieve our goals by forming alliances, supporting policies, improving Canada’s regulatory environment, widening access to innovative medicines and ensuring the effective protection of intellectual property.
We believe in ensuring that Canadians have access to the innovative treatments they need. Our activities are a fundamental part of safeguarding our healthcare system for future generations.
Inspiration Research
Inspiration Research Limited (IRL) is an independent company founded in 2003 by Dr. Kenneth Chapman. His vision for Inspiration Research is to educate patients to better manage their diseases and contribute to the advancement of novel therapies. Since inception, Inspiration Research has successfully completed over 70 human clinical studies with leading global pharmaceutical and biotechnology companies including GlaxoSmithKline, Merck, Novartis, Boehringer Ingelheim, Amgen, AstraZeneca, Nycomed, Schering-Plough, and Forest Laboratories.Currently, IRL specializes in clinical studies with patients diagnosed with asthma, heart disease and COPD.
In addition, IRL operates a pulmonary function test laboratory. Pulmonary function tests are valuable tools for doctors to diagnose patients with asthma, COPD, and other respiratory disease.